InvestorsObserver
×
News Home

TherapeuticsMD Inc (TXMD) Down 7.03% in Premarket Trading

Tuesday, May 24, 2022 06:56 AM | InvestorsObserver Analysts

Mentioned in this article

TherapeuticsMD Inc (TXMD) Down 7.03% in Premarket Trading

TherapeuticsMD Inc (TXMD) is lower by Tuesday morning, with the stock decreasing -7.03% in pre-market trading to 2.38. TXMD's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, TherapeuticsMD Inc ranks higher than 32% of stocks. TherapeuticsMD Inc has fallen 77.00% over the past month, closing at $11.22 on April 26. During this period of time, the stock fell as low as $2.27 and as high as $11.99. TXMD has an average analyst recommendation of Buy. The company has an average price target of $27.00.

Overall Score - 51
TXMD has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on TXMD!
TherapeuticsMD Inc has a Long-Term Technical rank of 40. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 60% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 117 by this metric, TXMD ranks better than 46% of stocks.

Important Dates for Investors in TXMD:

-TherapeuticsMD Inc is set to release earnings on 8/14/2022. Over the last 12 months, the company has reported EPS of $-21.50. -We do not have a set dividend date for TherapeuticsMD Inc at this time. Click Here To Get The Full Report on TherapeuticsMD Inc (TXMD)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App